Protocol for Radiofrequency Ablation of Pulmonary Neoplasms

Not Applicable

Terminated

• Conditions: Pulmonary Neoplasms

• Registration Number: NCT00232128
• Lead Sponsor: Oncology Specialties, Alabama

Brief Summary

This research trial involves the development of a new treatment for lung tumors. It is for patients whose tumor cannot be surgically removed, have refused surgery, or the tumor has not responded well to other forms of treatment. This treatment uses a needle probe to deliver energy into the lung tumor. This probe is placed utilizing a CT scan image. The energy heats the tumor causing tumor cell death.

Detailed Description

Not available

Study Timeline

• Study Start: 2003-06
• Study First Submitted: 2005-10-03
• Study First Submitted QC: 2005-10-03
• Study First Posted: 2005-10-04
• Status Verified: 2006-05
• Last Update Submitted: 2007-01-11
• Last Update Posted: 2007-01-12

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

The patients enrolled in this study should be judged to have sufficient survival to benefit from control of local disease and include at least one of the following:

1. unresectable primary or metastatic lung tumors
2. may benefit from multiple modalities of therapy
3. chemotherapeutic or radiation oncologic options have been exhausted

Exclusion Criteria

1. co-existing morbidities that preclude the use of surgery

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Trial Locations

Locations (1)

Comprehensive Cancer Institute; 🇺🇸 Huntsville, Alabama, United States